120 related articles for article (PubMed ID: 3276403)
1. Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro.
Wong HL; Wilson DE; Jenson JC; Familletti PC; Stremlo DL; Gately MK
Cell Immunol; 1988 Jan; 111(1):39-54. PubMed ID: 3276403
[TBL] [Abstract][Full Text] [Related]
2. Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro.
Gately MK; Wilson DE; Wong HL
J Immunol; 1986 Feb; 136(4):1274-82. PubMed ID: 2418110
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
Alderson MR; Sassenfeld HM; Widmer MB
J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
[TBL] [Abstract][Full Text] [Related]
4. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
Okada M; Kitahara M; Kishimoto S; Matsuda T; Hirano T; Kishimoto T
J Immunol; 1988 Sep; 141(5):1543-9. PubMed ID: 3261754
[TBL] [Abstract][Full Text] [Related]
5. Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines.
Uchida A; Fujimoto T; Mizutani Y
Cancer Immunol Immunother; 1990; 31(1):60-4. PubMed ID: 2106392
[TBL] [Abstract][Full Text] [Related]
6. Cytokine combinations for induction of antigen-specific cytolytic T lymphocytes from peripheral blood lymphocytes.
Tsujitani S; Nakashima M; Watanabe T; Kaibara N; Koprowski H; Steplewski Z
Anticancer Res; 1995; 15(3):655-60. PubMed ID: 7645938
[TBL] [Abstract][Full Text] [Related]
7. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.
Mehrotra PT; Wu D; Crim JA; Mostowski HS; Siegel JP
J Immunol; 1993 Sep; 151(5):2444-52. PubMed ID: 8103066
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory influence of IL-4 on human B cell responsiveness.
Jelinek DF; Lipsky PE
J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
Gajewski TF; Fitch FW
J Immunol; 1988 Jun; 140(12):4245-52. PubMed ID: 2967332
[TBL] [Abstract][Full Text] [Related]
10. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
11. Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytes.
Nakanishi M; Kan N; Okino T; Satoh K; Mise K; Teramura Y; Yamasaki S; Ohgaki K; Tobe T
Biotherapy; 1990; 2(1):21-32. PubMed ID: 2119201
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferons.
Chae F; Oleszak E; Fox FE; Trotta P; Mele CA; Hawrylko E; Platsoucas CD
Int Arch Allergy Appl Immunol; 1988; 86(4):361-9. PubMed ID: 2970436
[TBL] [Abstract][Full Text] [Related]
13. Interaction between cytokines and 8-mercaptoguanosine in humoral immunity: synergy with interferon.
Goodman MG
J Immunol; 1987 Jul; 139(1):142-6. PubMed ID: 3108396
[TBL] [Abstract][Full Text] [Related]
14. IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P).
Hladik F; Kolbe K; Irschick EU; Aman MJ; Gerken G; Färber L; Liehl E; Peschel C; Aulitzky WE; Huber C
Ann Hematol; 1993 Aug; 67(2):67-74. PubMed ID: 8347732
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
16. Bioassays for the detection of a cytokine that enhances the development of cytolytic T lymphocytes.
Cernetti C; Steinman RM; Granelli-Piperno A
Cell Immunol; 1987 Oct; 109(1):148-58. PubMed ID: 3308122
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated effector cells: modulation of activity by cytokines.
Mehta S; Flanagan P; Blackinton D; Wanebo H
Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 5 is a differentiation factor for cytotoxic T lymphocytes.
Ramos T
Immunol Lett; 1989 Jun; 21(4):277-83. PubMed ID: 2527815
[TBL] [Abstract][Full Text] [Related]
20. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
Brunda MJ; Tarnowski D; Davatelis V
Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
